These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18194504)

  • 21. Investigation of gastroduodenal mucosal injuries caused by low-dose aspirin therapy in patients with cerebral infarction.
    Nema H; Kato M
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S119-21. PubMed ID: 20586852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial.
    Goldstein JL; Cryer B; Amer F; Hunt B
    Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastrointestinal safety of NO-aspirin (NCX-4016) in healthy human volunteers: a proof of concept endoscopic study.
    Fiorucci S; Santucci L; Gresele P; Faccino RM; Del Soldato P; Morelli A
    Gastroenterology; 2003 Mar; 124(3):600-7. PubMed ID: 12612897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A blinded endoscopic comparative study of misoprostol versus sucralfate and placebo in the prevention of aspirin-induced gastric and duodenal ulceration.
    Lanza F; Peace K; Gustitus L; Rack MF; Dickson B
    Am J Gastroenterol; 1988 Feb; 83(2):143-6. PubMed ID: 3124604
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Helicobacter pylori and gastric adaptation to repeated aspirin administration in humans.
    Konturek JW; Dembiński A; Konturek SJ; Domschke W
    J Physiol Pharmacol; 1997 Sep; 48(3):383-91. PubMed ID: 9376621
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of Helicobacter pylori infection in gastroduodenal injury and gastric prostaglandin synthesis during long term/low dose aspirin therapy: a prospective placebo-controlled, double-blind randomized trial.
    Feldman M; Cryer B; Mallat D; Go MF
    Am J Gastroenterol; 2001 Jun; 96(6):1751-7. PubMed ID: 11419825
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind, double-dummy endoscopic comparison of the mucosal protective effects of misoprostol versus ranitidine on naproxen-induced mucosal injury to the stomach and duodenum in rheumatic patients.
    Bianchi Porro G; Lazzaroni M; Petrillo M
    Am J Gastroenterol; 1997 Apr; 92(4):663-7. PubMed ID: 9128319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of rabeprazole on regional gastric acidity and the postprandial cardia/gastro-oesophageal junction acid layer in normal subjects: a randomized, double-blind, placebo-controlled study.
    Vo L; Simonian HP; Doma S; Fisher RS; Parkman HP
    Aliment Pharmacol Ther; 2005 Jun; 21(11):1321-30. PubMed ID: 15932362
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An open-label, parallel, multiple-dose study comparing the pharmacokinetics and gastric acid suppression of rabeprazole extended-release with esomeprazole 40 mg and rabeprazole delayed-release 20 mg in healthy volunteers.
    Morelli G; Chen H; Rossiter G; Rege B; Lu Y
    Aliment Pharmacol Ther; 2011 Apr; 33(7):845-54. PubMed ID: 21272047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of low-dose aspirin on gastric erosions, cyclooxygenase expression and mucosal prostaglandin-E2 do not depend on Helicobacter pylori infection.
    Venerito M; Treiber G; Wex T; Kuester D; Roessner A; Di Mario F; Malfertheiner P
    Aliment Pharmacol Ther; 2006 Apr; 23(8):1225-33. PubMed ID: 16611284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term prevention of erosive or ulcerative gastro-oesophageal reflux disease relapse with rabeprazole 10 or 20 mg vs. placebo: results of a 5-year study in the United States.
    Caos A; Breiter J; Perdomo C; Barth J
    Aliment Pharmacol Ther; 2005 Aug; 22(3):193-202. PubMed ID: 16091056
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Helicobacter pylori infection, but not low-dose aspirin, results in a local reduction of the secretory leukocyte protease inhibitor in gastroduodenal mucosa.
    Wex T; Ye S; Treiber G; Vieth M; Roessner A; Malfertheiner P
    Helicobacter; 2006 Feb; 11(1):31-8. PubMed ID: 16423087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does nimesulide induce gastric mucosal damage? "A double-blind randomized placebo-controlled trial".
    Kapicioglu S; Baki AH; Sari M; Ozdemir F; Kavgaci H
    Hepatogastroenterology; 2000; 47(34):1183-5. PubMed ID: 11020910
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of gastroduodenal damage with omeprazole in patients receiving continuous NSAIDs treatment. A double blind placebo controlled study.
    Bianchi Porro G; Lazzaroni M; Petrillo M; Manzionna G; Montrone F; Caruso I
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):43-7. PubMed ID: 9615264
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of gastric and duodenal mucosal defects caused by low-dose aspirin in patients with ischemic heart disease.
    Nema H; Kato M; Katsurada T; Nozaki Y; Yotsukura A; Yoshida I; Sato K; Kawai Y; Takagi Y; Okusa T; Takiguchi S; Sakurai M; Asaka M
    J Clin Gastroenterol; 2009 Feb; 43(2):130-2. PubMed ID: 18779739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoscopic comparison of three aspirin preparations and placebo.
    Petroski D
    Clin Ther; 1993; 15(2):314-20. PubMed ID: 8519040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ethanol, aspirin, ibuprofen, and the gastroduodenal mucosa: an endoscopic assessment.
    Lanza FL; Royer GL; Nelson RS; Rack MF; Seckman CC
    Am J Gastroenterol; 1985 Oct; 80(10):767-9. PubMed ID: 4036935
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevalence of gastroduodenal mucosal injuries in aspirin users.
    Thongbai T
    J Med Assoc Thai; 2013 Nov; 96(11):1423-7. PubMed ID: 24428091
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Endoscopic changes in the stomach and duodenal mucosa caused by minidose acetylsalicylic acid therapy and their prevention].
    Novotný I; Díte P; Kunovská M; Münzová H
    Vnitr Lek; 2007 Oct; 53(10):1053-6. PubMed ID: 18072429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytoprotective effect of rabeprazole against ethanol-induced gastric mucosal damage: possible involvement of nitric oxide.
    Watanabe T; Higuchi K; Tominaga K; Fujiwara Y; Arakawa T
    Drugs Exp Clin Res; 2000; 26(2):41-5. PubMed ID: 10894554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.